Video Corner: Research Advances
From mechanisms at the gut level and the micro flora to the spinal cord and brain our understanding to the functional disorders has grown tremendously over the past 5 years. In these videos Emeran Mayer, MD and Lin Chang, MD, both from UCLA, and Brooks Cash, MD from Bethesda, Maryland explain some of these advances.
On one end new techniques allow us to probe the living human brain to understand its structure, activity, and receptor systems. On the other end we are just beginning to view the universe of our gut micro flora and the cross-talk taking place between it and the brain. Growing understanding of the ways in which many systems within the body interact has implications for various disorders such as pain, irritable bowel syndrome, fibromyalgia, interstitial cystitis, gastroparesis, and others. Like a jigsaw puzzle, many pieces are beginning to emerge.
But at the same time, resources that have been funding new and established research is drying up. We need to help ourselves. Every bit helps – donate now to IFFGD.
Emeran Mayer, MD, Director of the Center for Neurovisceral Sciences & Women's Health at UCLA talks about recent advances in our understanding of functional disorders.
CRF (corticotropin-releasing factor) is a peptide that interacts with many areas in the brain and the gut including those involved with digestive function, emotions, and autonomic nervous system activity. Dr. Mayer talks about our emerging understanding of CRF, which may have important applications for future treatments.
Brain and gut changes can interact to influence symptoms. Lin Chang, MD talks about their importance. Dr. Chang is Co-Director of the Center of Neurovisceral Sciences & Women’s Health at UCLA, Los Angeles, CA.
Advances in research ultimately lead to advances in clinical interactions. Brooks Cash, MD, USN, is Chief, Gastroenterology Division and Colon Health Initiative; and Associate Professor of Medicine, National Naval Medical Center, Bethesda, MD. Dr. Cash speaks about improvements in diagnosing functional GI disorders. He also talks about challenges to finding better treatments and looks ahead to newer therapies that are being developed.